about
Molecular Dynamics Simulations of apo and holo forms of Fatty Acid Binding Protein 5 and Cellular Retinoic Acid Binding Protein II Reveal Highly Mobile Protein, Retinoic Acid Ligand, and Water Molecules.Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions.MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers.Ligand activation of peroxisome proliferator-activated receptor-β/δ suppresses liver tumorigenesis in hepatitis B transgenic micePeroxisome proliferator-activated receptor-β/δ inhibits human neuroblastoma cell tumorigenesis by inducing p53- and SOX2-mediated cell differentiation.Design and Synthesis of Highly Active Peroxisome Proliferator-Activated Receptor (PPAR) β/δ Inverse Agonists with Prolonged Cellular Activity.Antihypertensive effects of peroxisome proliferator-activated receptor-β/δ activation.PPARs and nonalcoholic fatty liver disease.Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.Prostaglandin terminal synthases as novel therapeutic targets.Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis.ROS release by PPARβ/δ-null fibroblasts reduces tumor load through epithelial antioxidant response.Metabolism and Transcription in Cancer: Merging Two Classic Tales.Lipid metabolism and lipophagy in cancer.Peroxisome proliferator-activated receptor-β/δ modulates mast cell phenotype.PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders.PPARβ/δ Agonist GW501516 Inhibits Tumorigenicity of Undifferentiated Nasopharyngeal Carcinoma in C666-1 Cells by Promoting Apoptosis.Mutual interaction between oxidative stress and endoplasmic reticulum stress in the pathogenesis of diseases specifically focusing on non-alcoholic fatty liver disease
P2860
Q30152626-4C97AD86-B692-4116-8819-9C8C8E4F1DECQ37578702-15BD022C-9931-43E2-ACD5-63D64A5938CFQ37607478-05B4ECD7-D106-4C7D-98F0-CF3B7C8155F2Q37613094-4F3F7621-98F6-497A-B4CC-1CBEAF02A806Q38725289-7A8ECBFF-B542-4E53-A214-7347C9EC61B1Q38909807-EE0A34BE-9A5C-4BD4-802A-612C95022391Q39018398-115CDE62-3A32-4D31-9DE2-3D758857B473Q39029023-EA20C264-6679-4DE8-A046-0D275E83FD67Q39379510-A269AFB8-308F-45A7-B465-D84277ED59D6Q46263032-51898859-9504-4AF2-A342-5B9FEBCBDD35Q47897178-E803B514-C0AB-461B-B4E9-C0F7F9DA50F7Q48171317-C957C4C7-FD1D-4F29-9BF3-F5A213519E0EQ49306241-E1CFDE83-BD66-44C4-A725-369DE3451F0CQ50040248-CE298E1F-C6A3-4652-BD9A-3C28BA1E4297Q51276646-EB7DC514-D7E6-4C69-AED1-3335142FBAE3Q53825590-1C1C7576-A835-4D43-B522-F7C2126D94FDQ55656264-3EFAEE84-08EE-4EE6-B0AC-EE49B5932EFAQ58604208-6CC81A0A-469E-4F1D-8A0C-A2CE0311D50C
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Establishing the Role of PPARβ/δ in Carcinogenesis
@ast
Establishing the Role of PPARβ/δ in Carcinogenesis
@en
type
label
Establishing the Role of PPARβ/δ in Carcinogenesis
@ast
Establishing the Role of PPARβ/δ in Carcinogenesis
@en
prefLabel
Establishing the Role of PPARβ/δ in Carcinogenesis
@ast
Establishing the Role of PPARβ/δ in Carcinogenesis
@en
P2860
P1476
Establishing the Role of PPARβ/δ in Carcinogenesis
@en
P2093
Frank J Gonzalez
P2860
P304
P356
10.1016/J.TEM.2015.09.004
P577
2015-10-17T00:00:00Z